Cystatin C, renal disease, amyloidosis and antibiotics
41 – 50 of 129
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1998
-
Mark
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
(
- Contribution to journal › Article
-
Mark
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration
(
- Contribution to journal › Article
-
Mark
Serum cystatin C as a determinant of glomerular filtration rate in children
(
- Contribution to journal › Article
-
Mark
Screening for weak monoclonal antibodies in hybridoma technology
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1997
-
Mark
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes
(
- Contribution to journal › Article
-
Mark
Cystatin C, and inhibitor of bone resorption produced by osteoblasts
(
- Contribution to journal › Article
-
Mark
Long-term Stability of Albumin, Protein HC, Immunoglobulin G, κ- and λ-chain-immunoreactivity, Orosomucoid and α1-antitrypsin in Urine Stored at -20°C
(
- Contribution to journal › Article
-
Mark
Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases
(
- Contribution to journal › Article
- 1996
-
Mark
Renal handling of radiolabelled human cystatin C in the rat
(
- Contribution to journal › Article
-
Mark
Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus
(
- Contribution to journal › Article